DAB.bio

📍 Delft, Netherlands👥 35 employees💰 Last funded 2019
Biotechnology Research🌐 dab.bio
Website LinkedIn
DAB.bio develops and deploys cutting-edge fermentation technology. Our unique and patented FAST platform (Fermentation Accelerated by Separation Technology) enables continuous fermentation with cost reductions of 20-50% or more and is one of the most significant fermentation innovations of the past decade. The global focus on synthetic biology has delivered breakthrough routes to replace fossil-based chemicals with sustainable bio-based alternatives. High manufacturing costs currently hamper the large-scale manufacturing of many of these alternatives. FAST addresses this issue head-on. It is the largest contributor to lowering manufacturing costs and facilitating large-scale deployment of bio-based chemicals. DAB.bio promises a significant impact.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Netherlands
2
Frequently asked questions
Who invested in DAB.bio?
DAB.bio has 2 investors on record on gritt.io.
When did DAB.bio last raise funding?
The most recent investment in DAB.bio recorded on gritt.io was in 2019.
What industry is DAB.bio in?
DAB.bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is DAB.bio based?
DAB.bio is headquartered in Delft, Netherlands.